Hold onto your hats, baseball fans, because there’s a potential mega-trade brewing that could shake the MLB landscape more than any Skubal deal ever could. But here’s where it gets controversial: the Los Angeles Dodgers might not be eyeing Tarik Skubal as their top pitching upgrade. Instead, all signs point to Sandy Alcantara as the real game-changer—if they’re willing to take a calculated risk. Let’s break it down.
First, let’s address the Skubal chatter. Yes, his name is floating around because he’s in the final year of a $32 million contract, but the Detroit Tigers are unlikely to move him until the deadline, if at all. Meanwhile, Alcantara—a former Cy Young winner—is quietly emerging as a more intriguing option. After battling back from Tommy John surgery in 2024, the 30-year-old has shown glimpses of his old self, despite a lackluster 5.36 ERA in 2025. And this is the part most people miss: his performance improved as the season progressed, hinting that he might be on the cusp of a comeback.
So, why is Alcantara’s trade value so low? It’s simple: injury concerns. Coming off major elbow surgery, there’s always the risk of recurrence. However, Alcantara himself has stated he feels better than he has in years. At Marlins media day, he reflected, ‘Coming back from TJ, you’re not going to do great since the first day… I’ve just got to be able to be healthy this year and show people I can do great.’ Those words carry weight, especially for a team like the Dodgers, who could buy low on a pitcher with ace potential.
Here’s the kicker: the Dodgers don’t need another frontline starter. Their rotation is already stacked with names like Yoshinobu Yamamoto and Blake Snell. But this is the Dodgers we’re talking about—a franchise that thrives on dominance, not complacency. Bold prediction: Andrew Friedman will make a move this season, and Alcantara could be the bargain acquisition that pays off big time. Imagine pairing him with LA’s elite coaching and medical staff—it’s a recipe for revival.
Now, let’s talk trade specifics. The Marlins would likely accept a package centered around a proven MLB-level player like Sheehan and a top-10 Dodgers prospect. While River Ryan’s name has been floated, Miami might prefer a mix of talent to rebuild their roster. Controversial question: Are the Marlins waiting too long to trade Alcantara? By holding onto him post-surgery, they’ve watched his value plummet. Their best move now is to capitalize on his name recognition before the deadline—or risk losing even more leverage.
For the Dodgers, this trade isn’t about filling a hole; it’s about elevating an already strong rotation to championship-caliber. With Alcantara’s affordable contract (including a 2027 club option) and upside, he’s a low-risk, high-reward target. Sure, his injury history is a red flag, but so is half of LA’s pitching staff’s. The difference? Depth. Adding Alcantara increases the odds that at least a few of these former aces stay healthy—and that’s enough to chase a three-peat.
Final thought: This trade makes sense for both sides, but it’s the Dodgers who stand to gain the most. Alcantara needs a change of scenery, and LA is the perfect place for him to reclaim his stardom. So, what do you think? Is Alcantara worth the gamble, or should the Dodgers steer clear? Let’s hear your take in the comments!
